Could a smart wearable spot COVID-19 before symptoms start?
NCT ID NCT05035420
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tested a noninvasive wearable device that measures breathing, heart rate, body temperature, and oxygen levels. Researchers wanted to see if it could help screen for and monitor respiratory infections like COVID-19. Forty healthy adults performed breathing tasks while the device was compared to standard monitors. The goal was to validate the device's accuracy, not to treat or diagnose disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- noninvasive multimodal biosensing device
- What this could lead to
- If successful, this device could offer a simple, wearable way to screen for respiratory infections and monitor recovery at home.
- What could go wrong
- This is a very small pilot study with only 40 healthy adults, not patients. It tests the device's accuracy in a lab, not real-world use. The device may not work as well in sick people or outside controlled conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?